Cardiology

For patients with heart failure, the influenza vaccine can result in a mortality reduction up to 50% in season and 20% out of season.

Listening to music may help prolong exercise and participation, and may possibly have broader implications for exercise.

Findings suggest climate change may increase MI risk.

The risk of myocardial infarction was 2.4-fold higher in patients on short-term P2Y12 inhibitors after 18 months and 5.1-fold higher from month 6 to month 18.

Andexanet was shown to reduce FXa inhibition activity by 91% for patients on apixaban, 88% for patients on rivaroxaban, and 75% for patients on enoxaparin.

No events of primary endpoint occurred in PFO closure arm, whereas it developed in 6 of 60 patients receiving medication therapy alone.

Aggressive supplementation with vitamin D3 just before and after surgery can completely eliminate the observed drop.

As canakinumab lowers hsCRP, as well as interleukin-6, without a negative effect on lipid levels, it characterizes a new class of atherosclerosis medications.

The combined efforts of coaxing from barbers and monthly in-shop care from pharmacists resulted in 63.6% of the cohort achieving target BP levels.

At 6 weeks 68% of those receiving the Triple Pill achieved a blood pressure within their target range, versus 44% of those receiving usual care.

The CVD-REAL 2 study found that compared with other glucose-lowering drugs, SGLT-2 inhibitors reduce all-cause death, hospitalization for heart failure, myocardial infarction, and stroke.

While receiving a large dose of statin therapy did not have an impact on major adverse cardiac events among a broad population of patients, those that underwent percutaneous coronary intervention saw reductions.

Patients that were more optimistic had fewer heart-related hospital visits.

The mSToPS trial revealed a wearable ECG patch can markedly increase the AFib diagnosis rate relative to routine care—as much as 9-fold in the short-term and 3-fold in the long-term.

MOMENTUM 3 found that advanced heart-failure patients with an implanted centrifugal-flow circulatory pump had lower rates of pump-related blood clots and stroke.

Studies reveal short- and long-term effects of heart changes in college and professional football players.

The use of instantaneous wave-free ratio can reportedly save each patient at least $800 in comparison with fractional flow reserve.

While full parity may be impossible, a 4-step protocol did decrease discrepancies in clinical outcomes and mortality between men and women.

Clinicians have been shown to be influenced by their patients’ genetic makeup when prescribing antiplatelet therapies.

All-cause mortality and death due to stroke, however, were 1.8% and 0.5% lower, respectively, in the group utilizing WCD.

Study sheds new light on potential risks and benefits of aspirin for people with both conditions.

The trial showed alirocumab reduced MACE by 24% with an ARR of 3.4% and all-cause death by 29% with an ARR of 1.7% in patients with ACS and baseline LDL-C ≥100 mg/dL.

The therapies come on the tail of Amgen's failed attempt to receive a 6-month exclusivity extension for Sensipar.

Significant discrepancies are found between ASCVD guidelines and primary care management of HIV patients in the military health system.

Will results of a study comparing a new formula for evaluating LDL-C in the nonfasting state and the Friedewald method turn heads?

The expanded approval of the heart valve makes it the smallest mechanical heart valve approved in the world, a size small enough to be used in newborn pediatric patients to treat heart defects.

Despite prior evidence showing that those with CVD live longer if they are overweight or obese at the time of diagnosis leading to confusion, new data has shed light on why this paradox exists.

Varicose veins were rarely thought to have severe health effects, but should now be monitored closely, new evidence suggests.

This meta-analysis does not provide support for current recommendations to use omega-3 fatty acid supplements for the prevention of cardiovascular disease risk.